...
首页> 外文期刊>Biopreservation and biobanking >Advancing Professionalization of Biobank Business Operations: Performance and Utilization
【24h】

Advancing Professionalization of Biobank Business Operations: Performance and Utilization

机译:推进BIOBANK业务运营的专业化:性能和利用

获取原文
获取原文并翻译 | 示例
           

摘要

Biobanks are now in the spotlight as key enablers supporting preclinical, clinical, and environmental research. Awareness of their value has increased along with the need for these infrastructures to be sustained through business-focused practices. Following our 2017 pilot survey on biobank business planning, we initiated a more comprehensive 38-question multiple-language worldwide survey on biobank sustainability. Two hundred seventy-six biobanks of various sizes and stages of business planning (in place, in progress or none) responded. About two-thirds were established in the last 10 years. Survey results confirm our hypothesis that biobanks with business plans or preparing such plans are trending toward more professional structures. Specific survey data focusing on performance metrics and utilization, as related to sustainability, are presented. Biobanks most frequently measured basic performance metrics (sample utilization, samples collected, samples distributed, internal projects supported). Metrics less often reported included sample and data quality, cost recovery, citations, and publications, typically correlating with higher levels of biobank complexity and professionalism. Biobanks reported supporting projects for both internal and external use, with support of projects within their own organizations as the main driver of biobanks, independent of business plan status. Having a business plan seemed to be a key factor for biobanks that had developed sustained support for external commercial projects. While under half of the biobanks reported both target and actual utilization rates, the responses provided valuable data on utilization. Target utilization rates were much higher (2.5 to 5 times higher) than the rate of actual use. Many of the biobanks report less than 10% utilization. Biobanks with low utilization rates make sustainability a very distant and likely unreachable goal. Our survey has provided some basic data about biobank business planning globall
机译:Biobanks现在在聚光灯中作为支持临床前,临床和环境研究的关键推动力。对其价值的认识随着这些基础设施的需求而通过专注的实践来维持。在2017年关于Biobank业务规划的飞行员调查之后,我们在Biobank可持续发展中启动了一个更加全面的38个问题全球全球调查。两百七十六个生物银行的各种尺寸和业务规划阶段(进入到位或没有)回应。在过去的10年里建立了大约三分之二。调查结果证实了我们的假设与商业计划或准备这些计划的生物汉正在走向更专业的结构。提出了与可持续性相关的绩效指标和利用的具体调查数据,如有与可持续性相关。 Biobanks最常用的基本性能指标(采样利用率,收集的样本,分布式的样本,支持的内部项目)。较少报告的指标包括样本和数据质量,成本恢复,引用和出版物,通常与较高水平的生物人物复杂性和专业性相关。 Biobanks报告了支持内部和外部使用的项目,并支持自己组织内的项目作为BioBanks的主要驱动因素,与商业计划状况无关。拥有业务计划似乎是对外部商业项目的持续支持的生物人士的关键因素。虽然BIOBANK的一半报告了目标和实际利用率,但答案提供了有价值的利用数据。目标利用率远高于实际使用率高(更高的2.5至5倍)。许多BIOBANKS报告的利用率不到10%。利用率低的BioBanks使可持续发展成为一个非常遥远的并且可能无法到达的目标。我们的调查提供了有关Biobank业务计划Globall的一些基本数据

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号